ALLMedicine Implantable Cardioverter-defibrillators Center

May 29th, 2020 - Background There are conflicting data regarding the benefit of primary prevention implantable cardioverter-defibrillators (ICDs) in patients with diabetes mellitus and heart failure (HF) with reduced ejection fraction. We aimed to assess the compa...

May 16th, 2020 - Post-implant recovery in patients with implantable cardioverter-defibrillators (ICDs) is often compromised because of reduced physical and psycho-cognitive function and poor health perception, leading to short event-free survival. To examine the e...

May 5th, 2020 - The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective investigator-initiated, controlled cohort study, was conducted in 44 centres and 15 Euro...

Apr 30th, 2020 - Patients with long QT syndrome (LQTS) are predisposed to life-threatening arrhythmias. A delay in cardiac repolarization is characteristic of the disease. Pharmacotherapy, implantable cardioverter-defibrillators, and left cardiac sympathetic dener...

Apr 30th, 2020 - Inaccurate arrhythmia classification by implantable cardioverter-defibrillators (ICD) contributes to inappropriate shocks and increased healthcare utilization. This study sought to evaluate the ability of a novel discriminator using far-field (FF)...

Sep 13th, 2017 - The statement focuses on identifying the presence of lead malfunction, deciding on whether to abandon or to extract a lead that is no longer clinically necessary or at higher risk for failure, offering guidance on whether a cardiovascular implanta.

Jan 19th, 2011 - Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the american society of anesthesiologists task force on periop...

May 29th, 2020 - Background There are conflicting data regarding the benefit of primary prevention implantable cardioverter-defibrillators (ICDs) in patients with diabetes mellitus and heart failure (HF) with reduced ejection fraction. We aimed to assess the compa...

May 16th, 2020 - Post-implant recovery in patients with implantable cardioverter-defibrillators (ICDs) is often compromised because of reduced physical and psycho-cognitive function and poor health perception, leading to short event-free survival. To examine the e...

May 6th, 2020 - Any resistance to the reuse of implantable devices with years of remaining life in them often come from concerns that they pose a high risk for infection in the new recipient. But decades of experience in exporting reconditioned and resterilized d...

May 5th, 2020 - The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective investigator-initiated, controlled cohort study, was conducted in 44 centres and 15 Euro...

Apr 30th, 2020 - Patients with long QT syndrome (LQTS) are predisposed to life-threatening arrhythmias. A delay in cardiac repolarization is characteristic of the disease. Pharmacotherapy, implantable cardioverter-defibrillators, and left cardiac sympathetic dener...

May 6th, 2020 - Any resistance to the reuse of implantable devices with years of remaining life in them often come from concerns that they pose a high risk for infection in the new recipient. But decades of experience in exporting reconditioned and resterilized d...

Oct 29th, 2019 - After ransomware attacks or other hacks, hospitals' heart attack mortality rates are higher, speculated to be due to delays in care from stronger passwords and other cybersecurity remediation. (PBS.org) Subcutaneous implantable cardioverter-defibr...

Oct 26th, 2019 - PARIS – Fewer than half of commercial drivers who received implantable cardioverter-defibrillators (ICDs) recalled being told they should never drive professionally again, according to a recent Danish survey. Further, about a third of patients ove.

Aug 5th, 2019 - Abbott is recalling Ellipse implantable cardioverter-defibrillators (ICDs) after reports that some devices have exposed aluminum wires. The US Food and Drug Administration (FDA) has classified this a class 1 recall, the most serious type, because ...

Jun 13th, 2019 - Electrophysiologists won out over interventionalists, general cardiologists, and thoracic surgeons as the specialty placing implantable cardioverter-defibrillators with the fewest long-term device-related complications. (Circulation: Cardiovascula...